October 31, 2025 a 12:38 pm
LH: Analysts Ratings - Labcorp Holdings Inc.
Labcorp Holdings Inc. has been consistently providing laboratory services that empower decision-making among a diverse clientele. The recent analyst ratings reflect a stable outlook, maintaining a predominantly positive sentiment with a significant fraction of ratings falling under the "Buy" category. Detailed monthly trend analysis indicates a consistent market position supported by strong buy recommendations.
Historical Stock Grades
Labcorp Holdings Inc. has shown a consistent performance as reflected by the latest analyst ratings in October 2025:
| Recommendation | Count | Score |
|---|---|---|
| Strong Buy | 2 | |
| Buy | 12 | |
| Hold | 5 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
The sentiment over the past months indicates stability in the Labcorp Holdings stock ratings. Although there are minor fluctuations, the dominant category remains the "Buy" recommendation.
- The number of "Strong Buy" ratings has decreased slightly from the previous months.
- A consistent number of analysts maintain a "Buy" recommendation, reflecting stable confidence.
- The "Hold" ratings have seen a slight increase, suggesting a cautious approach among some analysts.
- No movement in "Sell" or "Strong Sell" ratings, reinforcing the positive outlook.
Percentage Trends
Analyzing percentage trends over recent months reveals a noteworthy stability with minor category shifts.
- Strong Buy recommendations decreased marginally from earlier highs of 20% to 10%.
- Buy recommendations consistently hold a majority stake around 60%.
- Hold recommendations have shown a slight increase, currently at around 25%.
- The combined absence of Sell and Strong Sell recommendations suggests persistent positive sentiment.
Latest Analyst Recommendations
Recent analyst activities indicate a stable recommendation pattern with no major changes in stance.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-10-29 | Buy | Buy | UBS |
| 2025-10-17 | Buy | Buy | UBS |
| 2025-10-17 | Outperform | Outperform | Mizuho |
| 2025-10-03 | Outperform | Outperform | Evercore ISI Group |
| 2025-10-02 | Equal Weight | Equal Weight | Barclays |
Analyst Recommendations with Change of Opinion
Some analysts have adjusted their ratings in response to changing market dynamics over the past months.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-03-04 | Buy | Neutral | Citigroup |
| 2025-01-07 | Outperform | In Line | Evercore ISI Group |
| 2024-10-30 | Buy | Hold | HSBC |
| 2024-03-25 | Buy | Hold | Argus Research |
| 2022-12-12 | Neutral | Buy | Citigroup |
Interpretation
The continuance of positive analyst sentiment towards Labcorp Holdings suggests firm market confidence. With the persistence of "Buy" recommendations and static "Hold" ratings, there is a clear signal of stability in market perception. The absence of "Sell" ratings reflects a strong belief in the company's potential. However, the slight decrease in "Strong Buy" recommendations could indicate growing prudence among investors.
Conclusion
In summary, Labcorp Holdings Inc. maintains a strong position in the market with sustained support from analysts. While "Strong Buy" ratings have diminished slightly, the overall sentiment is predominantly positive. The presence of stability amidst minor fluctuations signifies both opportunities for steady growth and potential risks associated with cautious investor behavior. The data supports an outlook of enduring reliability, bolstered by recent confirmations of previous ratings.